Motion Sifnos: A randomized, double-blind, placebo-controlled study demonstrating the effectiveness of tradipitant in the treatment of motion sickness
View ORCID ProfileVasilios M. Polymeropoulos, View ORCID ProfileMark É. Czeisler, Mary M. Gibson, Austin A. Anderson, Jane Miglo, Jingyuan Wang, Changfu Xiao, View ORCID ProfileChristos M. Polymeropoulos, Gunther Birznieks, View ORCID ProfileMihael H. Polymeropoulos
doi: https://doi.org/10.1101/2020.04.06.20055715
Vasilios M. Polymeropoulos
1Vanda Pharmaceuticals, Washington, District of Columbia, United States of America
Mark É. Czeisler
1Vanda Pharmaceuticals, Washington, District of Columbia, United States of America
Mary M. Gibson
1Vanda Pharmaceuticals, Washington, District of Columbia, United States of America
Austin A. Anderson
1Vanda Pharmaceuticals, Washington, District of Columbia, United States of America
Jane Miglo
1Vanda Pharmaceuticals, Washington, District of Columbia, United States of America
Jingyuan Wang
1Vanda Pharmaceuticals, Washington, District of Columbia, United States of America
Changfu Xiao
1Vanda Pharmaceuticals, Washington, District of Columbia, United States of America
Christos M. Polymeropoulos
1Vanda Pharmaceuticals, Washington, District of Columbia, United States of America
Gunther Birznieks
1Vanda Pharmaceuticals, Washington, District of Columbia, United States of America
Mihael H. Polymeropoulos
1Vanda Pharmaceuticals, Washington, District of Columbia, United States of America

Article usage
Posted April 11, 2020.
Motion Sifnos: A randomized, double-blind, placebo-controlled study demonstrating the effectiveness of tradipitant in the treatment of motion sickness
Vasilios M. Polymeropoulos, Mark É. Czeisler, Mary M. Gibson, Austin A. Anderson, Jane Miglo, Jingyuan Wang, Changfu Xiao, Christos M. Polymeropoulos, Gunther Birznieks, Mihael H. Polymeropoulos
medRxiv 2020.04.06.20055715; doi: https://doi.org/10.1101/2020.04.06.20055715
Motion Sifnos: A randomized, double-blind, placebo-controlled study demonstrating the effectiveness of tradipitant in the treatment of motion sickness
Vasilios M. Polymeropoulos, Mark É. Czeisler, Mary M. Gibson, Austin A. Anderson, Jane Miglo, Jingyuan Wang, Changfu Xiao, Christos M. Polymeropoulos, Gunther Birznieks, Mihael H. Polymeropoulos
medRxiv 2020.04.06.20055715; doi: https://doi.org/10.1101/2020.04.06.20055715
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)